Efficacy and Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder

Lenard A. Adler; Brenda Zimmerman; H. Lynn Starr; Steve Silber; Joseph Palumbo; Camille Orman; Thomas Spencer

doi:10.1097/jcp.0b013e3181a390ce

Efficacy and Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder

Journal of Clinical Psychopharmacology ◽

10.1097/jcp.0b013e3181a390ce ◽

2009 ◽

Vol 29 (3) ◽

pp. 239-247 ◽

Cited By ~ 73

Author(s):

Lenard A. Adler ◽

Brenda Zimmerman ◽

H. Lynn Starr ◽

Steve Silber ◽

Joseph Palumbo ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Efficacy And Safety ◽

Hyperactivity Disorder

Download Full-text

Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study

CNS Drugs ◽

10.1007/s40263-013-0104-8 ◽

2013 ◽

Vol 27 (12) ◽

pp. 1081-1092 ◽

Cited By ~ 53

Author(s):

Ralf W. Dittmann ◽

Esther Cardo ◽

Peter Nagy ◽

Colleen S. Anderson ◽

Ralph Bloomfield ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Efficacy And Safety ◽

Lisdexamfetamine Dimesylate ◽

Double Blind ◽

Hyperactivity Disorder ◽

Phase Iiib

Download Full-text

Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled clinical trial

Advances in Integrative Medicine ◽

10.1016/j.aimed.2022.01.002 ◽

2022 ◽

Author(s):

Benyamin Pazoki ◽

Nadia Zandi ◽

Zeinab Assaf ◽

Hossein Sanjari Moghaddam ◽

Arefeh Zeinoddini ◽

...

Keyword(s):

Clinical Trial ◽

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Controlled Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder

Download Full-text

Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents

Archives of Clinical Psychiatry (São Paulo) ◽

10.1590/0101-60830000000007 ◽

2014 ◽

Vol 41 (2) ◽

pp. 34-39 ◽

Cited By ~ 2

Author(s):

Paulo Mattos

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Efficacy And Safety ◽

Lisdexamfetamine Dimesylate ◽

Hyperactivity Disorder

Download Full-text

Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2011.01.007 ◽

2011 ◽

Vol 50 (4) ◽

pp. 395-405 ◽

Cited By ~ 72

Author(s):

Robert L. Findling ◽

Ann C. Childress ◽

Andrew J. Cutler ◽

Maria Gasior ◽

Mohamed Hamdani ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Efficacy And Safety ◽

Lisdexamfetamine Dimesylate ◽

Hyperactivity Disorder

Download Full-text

A Double-Blind, Randomized, Placebo/Active Controlled Crossover Evaluation of the Efficacy and Safety of Ritalin® LA in Children with Attention-Deficit/Hyperactivity Disorder in a Laboratory Classroom Setting

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2009.0106 ◽

2010 ◽

Vol 20 (5) ◽

pp. 377-385 ◽

Cited By ~ 9

Author(s):

Eberhard Schulz ◽

Christian Fleischhaker ◽

Klaus Hennighausen ◽

Philip Heiser ◽

Klaus-Uwe Oehler ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Classroom Setting ◽

Efficacy And Safety ◽

Double Blind ◽

Hyperactivity Disorder ◽

Laboratory Classroom

Download Full-text

4.23 PIVOTAL PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF HLD200, A NOVEL DELAYED-RELEASE AND EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE, IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.09.218 ◽

2016 ◽

Vol 55 (10) ◽

pp. S170

Author(s):

Valerie K. Arnold ◽

Norberto J. DeSousa ◽

Bev Incledon ◽

Floyd R. Sallee ◽

Timothy E. Wilens ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Phase 3 ◽

Pivotal Phase ◽

Release Formulation ◽

Extended Release Formulation ◽

Hyperactivity Disorder ◽

Delayed Release

Download Full-text

A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children

Clinical Therapeutics ◽

10.1016/j.clinthera.2020.05.021 ◽

2020 ◽

Vol 42 (8) ◽

pp. 1452-1466 ◽

Cited By ~ 2

Author(s):

Azmi Nasser ◽

Tesfaye Liranso ◽

Toyin Adewole ◽

Nicholas Fry ◽

Joseph T. Hull ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Controlled Trial ◽

Phase Iii ◽

School Age Children ◽

School Age ◽

Efficacy And Safety ◽

Once Daily ◽

Hyperactivity Disorder

Download Full-text

Efficacy and Safety of Lisdexamfetamine Dimesylate [LDX; NRP104] in Children Aged 6 to 12 Years with Attention-Deficit/Hyperactivity Disorder

Journal of Developmental & Behavioral Pediatrics ◽

10.1097/00004703-200610000-00057 ◽

2006 ◽

Vol 27 (5) ◽

pp. 443 ◽

Cited By ~ 2

Author(s):

Joseph Biederman ◽

Hilary Mandler ◽

Suma Krishnan ◽

Robert L. Findling

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Efficacy And Safety ◽

Lisdexamfetamine Dimesylate ◽

Hyperactivity Disorder

Download Full-text

Efficacy and safety of tipepidine as adjunctive therapy in children with attention‐deficit/hyperactivity disorder: Randomized, double‐blind, placebo‐controlled clinical trial

Psychiatry and Clinical Neurosciences ◽

10.1111/pcn.12913 ◽

2019 ◽

Vol 73 (11) ◽

pp. 690-696 ◽

Cited By ~ 5

Author(s):

Sara Dehbozorghi ◽

Sayna Bagheri ◽

Kamyar Moradi ◽

Kamyar Shokraee ◽

Mohammad‐Reza Mohammadi ◽

...

Keyword(s):

Clinical Trial ◽

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Controlled Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder

Download Full-text

Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study

The World Journal of Biological Psychiatry ◽

10.3109/15622975.2011.600333 ◽

2011 ◽

Vol 14 (4) ◽

pp. 268-281 ◽

Cited By ~ 9

Author(s):

Miguel Casas ◽

Michael Rösler ◽

J. J. Sandra Kooij ◽

Ylva Ginsberg ◽

Josep Antoni Ramos-Quiroga ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Fixed Dose ◽

Prolonged Release ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Dose Study

Download Full-text